Chemotherapy Induced Neutropenia Treatment Market is driven by...

добавлена новая статья Другое

2 месяца назад -

Chemotherapy Induced Neutropenia Treatment Market is driven by increasing cancer prevalence and rising demand for targeted therapies.

Chemotherapy-induced neutropenia (CIN) is a common side effect of cancer treatment that occurs when the number of neutrophils, a type of white blood cell, decreases due to chemotherapy. Chemotherapy-induced neutropenia Market can lead to severe complications, such as infections and fever, which may require hospitalization and interruption of cancer treatment. The growing incidence of cancer...

0 Комментарии 0 Поделились 390 Просмотры 0 предпросмотр